Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Oncology | Obstetrics/Gynecology | Endocrinology
Ovarian Cancer
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Integration of Palliative Care in Use of Intra-Peritoneal Chemotherapy for Ovarian Cancer
Randomized Pilot Trial of Oral Cyclophosphamide versus Oral Cyclophosphamide with Celecoxib for Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Phase 2 study to evaluate the efficacy and safety of NKTR 102 (PEG-Irinotecan) when given on a Q14 day or a Q21 day schedule in patients with metastatic or locally advanced platinum-resistant ovarian cancer
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
GOG-136: Acquisition of human gynecologic specimens and serum to be used in studying the causes, diagnosis, prevention and treatment of cancer
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma (OCEANS)
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
A Study Comparing the Combination of Doxil and Yondelis, to Doxil Alone for Subjects With Ovarian Cancer
A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma (OCEANS)
A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Safety and Effectiveness of an Experimental drug for Reducing the Side-Effects of Chemotherapy Given for Recurrent Ovarian Cancer – Adults
Abnormal Pelvic Mass - Adults
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
A Phase II Evaluation of Lapatinib (GW572016) (NCI-Supplied Agent, NSC #727989, IND #70,252) in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma [GOG-0170-G]
A Phase II Evaluation of Triapine (NCI-Supplied Agent: NSC #663249, IND #68338)) in Combination with Cisplatin (Commercially Available: NSC #119875) in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma [GOG 0126-o]
A Phase II Randomized Study of the Effect of Zoledronic Acid Versus Observation on Bone Mineral Density of the Lumbar Spine in Woman who Elect to Undergo Risk-Reducing Surgery that Results in Removal of Both Ovaries [GOG0215]
A Randomized Study of Tamoxifen Versus Thalidomide (NSC# 66847) in Patients with Biochemical-Recurrence-Only-Epithelial Ovarian Cancer, Cancer of the Fallopian Tube, and Primary Peritoneal Carcinoma After First Line Chemotherapy [GOG-0198]
An Exploratory Evaluation of Fenretinide (4-HPR) (IND #39,812) as a Chemopreventive Agent for Ovarian Carcinoma [GOG0190]
Prospective Study of Risk-Reducing Salpingo-Ophorectomy and Longitudinal CA-125 Screening Among Women at Increased Genetic Risk of Ovarian Cancer [GOG 0199]
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Carcinoma Of The Ovary
Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Carcinoma Of The Uterine Cervix And/Or Vulva
Phase II Study Of Antineoplastons A10 And AS2-1In Patients With Adenocarcinoma Of The Stomach
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Women who plan to have their ovaries removed sought for research study.
Women with Ovarian or Peritoneal Cancer Sought for Research Study.
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Research Study of Carboplatin and DOXIL plus Bevacizumab in Patients with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
